| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 94 |
| 1 | RISPERIDONE | 15 |
| 2 | ESCITALOPRAM | 13 |
| 3 | ESCITALOPRAM OXALATE | 11 |
| 4 | QUETIAPINE | 11 |
| 5 | METHOTREXATE SODIUM | 10 |
| 6 | ADALIMUMAB | 9 |
| 7 | ARIPIPRAZOLE | 9 |
| 8 | ESCITSLOPRAM | 9 |
| 9 | METHOTREXATE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN, HYPROMELLOSE | 1 | 0.0043 |
| 1 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE | 1 | 0.0018 |
| 2 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE | 1 | 0.0017 |
| 3 | ERYTHROMYCIN ETHYLSUCCINATE | 1 | 0.0016 |
| 4 | FINASTERIDE | 94 | 0.0015 |
| 5 | ZIPRASIDONE HCL | 3 | 0.0011 |
| 6 | ILOPROST | 1 | 0.0011 |
| 7 | THYROTROPIN ALFA | 1 | 0.0010 |
| 8 | SELENIUM | 3 | 0.0007 |
| 9 | DUTASTERIDE | 5 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 100 |
| 1 | Atypical Antipsychotic [EPC] | 21 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 3 | Corticosteroid [EPC] | 11 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 9 |
| 5 | Mood Stabilizer [EPC] | 9 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 8 |
| 7 | Thalidomide Analog [EPC] | 8 |
| 8 | Alkylating Drug [EPC] | 7 |
| 9 | Anti-epileptic Agent [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 100 | 0.0010 |
| 2 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 6 | Alkaloid [EPC] | 5 | 0.0002 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |